Sequenom 8-K 2012
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 12, 2012
(Exact Name of Registrant as Specified in Charter)
3595 JOHN HOPKINS COURT
SAN DIEGO, CALIFORNIA 92121
(Address of Principal Executive Offices)
(Registrants telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
On April 12, 2012 we entered into a Second Amendment to Sale and Supply Agreement (the Amendment) with Illumina, Inc. (Illumina) amending that certain Sale and Supply Agreement we entered into with Illumina on July 8, 2011, as amended (the Supply Agreement). The Amendment extends the term of the Supply Agreement to a five year term, terminating in July 2016 unless earlier terminated as provided for in the Supply Agreement. The Amendment also adjusted the quantity and timing of the consumables, and the price of the instruments, being purchased by us pursuant to the Supply Agreement.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.